Wyeth/Progenics File Methylnaltrexone Injection NDA For Opioid-Induced Constipation
Companies will meet with FDA in May to discuss new study for an oral formulation, Wyeth tells “The Pink Sheet” DAILY.
Companies will meet with FDA in May to discuss new study for an oral formulation, Wyeth tells “The Pink Sheet” DAILY.